Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

View source ↗

Summary

Clinical trial update describing a survey of cabozantinib tablets used to treat hepatocellular carcinoma, sponsored by Takeda, with the study status listed as c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cabozantinib (cabozantinib)

Snippet

Sponsor: Takeda | Conditions: Hepatocellular Cancer | Status: COMPLETED